GLAXOSMITHKLINE

Britain's GlaxoSmithKline has agreed to pay billions of dollars to settle multiple U.S. pharmaceutical investigations.

U.S. vaccine advisers on Tuesday voted to recommend that boys be routinely vaccinated with Merck & Co's Gardasil vaccine to protect them from human papillomavirus or HPV infections, which cause genital warts and oral, penile and anal cancers in males and cervical cancers in women.

A new vaccine cuts children's chances of contracting malaria in half, according to a major clinical trial sub-Saharan Africa. It is the first successful malaria vaccine and could be an indispensable tool in the fight to eradicate the disease.

An experimental vaccine from GlaxoSmithKline halved the risk of African children getting malaria in a major clinical trial, making it likely to become the world's first shot against the deadly disease.

U.S. health officials are looking to capitalize on significant gains in flu vaccination rates with a new campaign emphasizing the need for all Americans over six months of age to get a flu shot.

The issue of the longevity gene has now created a feud between two trans-Atlantic camps of researchers. While the British scientists claim the days of longevity gene are over, the US scientists still have faith in the success of the gene.

A gene scientists say delivers the fountain of youth may just a bucket of water, according to research published today.

Scientists have found a way to prevent HIV from damaging the immune system and say their discovery may offer a new approach to developing a vaccine against AIDS.

This week, UCLA scientists are presenting research findings that indicate two popular diabetes medications may increase patients' risk of cancer.

South Africa's Aspen Pharmacare could spend some $800 million on acquisitions, its deputy CEO said, as Africa's biggest generic drugs maker looks for further targets, particularly in Latin America.

For the second year in a row, health experts are urging all Americans to get a flu shot, even though the circulating strains of flu have not changed since the 2010-2011 flu season.

Scientists say their discovery of "super antibody" FI6, which can fight all types of influenza A viruses that cause disease in humans and animals, may serve as a turning point in the development of new flu treatments.

Scientists have found a flu "super antibody" called FI6 that can fight all types of influenza A viruses that cause disease in humans and animals and say their discovery may be a turning point in the development of new flu treatments.

At least three private equity firms are planning to bid for a clutch of GlaxoSmithKline's non-prescription products, expecting limited competition from rival large pharma groups, people familiar with the process said.

A former Credit Suisse Group AG broker will spend two more years in prison in addition to time already served for his role in running an investment scheme involving risky auction-rate securities.

A group of major western pharmaceutical companies announced that they will significantly reduce the prices they charge for vaccines in the developing world.

The companies whose shares are moving in pre-market trade on Wednesday are: Corning, Baker Hughes, Carnival Corp, Boeing, Hess Corp, Merck & Co, GlaxoSmithKline, LDK Solar, FMC Technologies, Rockwell Automation and Johnson & Johnson.

Roche is set to kick off the Big Pharma reporting season with a fall in sales on Thursday as a strong Swiss franc, weak demand for top-selling cancer drug Avastin and lack of Tamiflu revenue take their toll.

XenoPort (NASDAQ: XNPT) and GlaxoSmithKline Plc (LON: GSK) said the U.S. Food and Drug Administration (FDA) has approved Horizant, a treatment for restless legs syndrome (RLS) that the companies developed together.

The top pre-market NASDAQ Stock Market gainers are: Xenoport, ZAGG, Bed Bath & Beyond, Immucor, Immunogen, and China Gerui Advanced Materials Group. The top pre-market NASDAQ Stock Market losers are: Qiao Xing Universal Resources, Travelzoo, Power-One, Advanced Energy Industries, and ASML Holding.

The top after-market NASDAQ Stock Market gainers are: Xenoport, Bed Bath & Beyond, Immucor, Fortinet, and Tesco. The top after-market NASDAQ Stock Market losers are: Power-One, Tuesday Morning, Advanced Analogic Technologies, ISTA Pharmaceuticals, and Lincare Holdings.